Fuzzy, you can only blame DM for not doing the right thing in stepping down after BOM and bringing in a experienced well respected Biotech executive who could have brought all the pieces together. DM is to blame and at this point a Hail Mary is required like a BP buyout at respectable price based on the huge potential. for god sake there is probably a $500 million tax loss for inquiring buyer add in the BTD and the huge potential with BOM2 and the long Covid trial and this is a no brainer for any BP to takeover , so what is the problem here of why nothing is happening yet??